Bal Pharma Ltd.
₹107.42
+1.14%
Delayed · cached 15 min
Price Chart
Price50-day avg200-day avg
How to read this: the line is the closing price over time. The two dashed lines are moving averages — the average price over the last 50 and 200 trading days — which smooth out daily noise to show the broader trend. Price above its moving averages reflects recent strength; below reflects recent weakness. Use the buttons to change the time range. Prices are end-of-day, not live.
✓Strengths
- Pays a dividend (yield about 1.12%).
- Has paid a dividend in each of the last 5 years on record.
- Promoters hold a majority stake (50.87%).
!Watch-points
- Higher leverage: debt-to-equity of 1.95 is above 1.
- Return on equity is on the lower side at 7.9%.
- Return on capital employed is on the lower side at 9.7%.
- Net profit margin is slim at 1.9%.
These points are generated automatically from the company’s reported figures to highlight what stands out. They are descriptive observations for educational purposes only — not advice or a recommendation to buy, sell, or hold.
Forensic Checks
Altman Z-ScoreDistress zone
1.63
In Altman’s study, scores in this range were associated with a higher incidence of financial distress.
Computed without the working-capital term (current-asset split not available for this stock).
Piotroski F-ScoreModerate
5 / 7
The F-Score adds one point for each of several year-on-year signs of improving profitability, lower leverage and better efficiency. Higher is generally stronger.
Based on 7 of the 9 signals — the rest need data not available for this stock.
These are well-known academic screening models, shown for educational context only. They describe historical financial patterns and are not predictions, advice, or a recommendation to buy, sell, or hold.
Key Ratios
Market Cap₹ 171 Cr
Current Price₹ 107.42
High / Low₹ 124.60 / 60.00
Stock P/E23.713022
Book Value₹ 51.60
Dividend Yield0%
ROCE9.69%
ROE7.87%
Face Value₹ 10.00
Debt to Equity1.95
PEG Ratio0.68
EV / EBITDA7.70
Industry PE35.70
P/B Ratio2.0771937
EPS₹ 3.94
Debt₹ 160 Cr
PAT Margin1.92%
Cash PAT₹ 17 Cr
ICR1.88
Promoter Holding50.87%
FII Holding0.15%
DII Holding—
Public Holding48.99%
Note on calculated ratios: where a value is not published in the source data, we compute it from the reported financials — Debt to Equity = total borrowings ÷ (equity capital + reserves); EV / EBITDA = (market cap + debt − cash) ÷ (operating profit + depreciation); PEG = P/E ÷ 3-year profit growth %. These may differ slightly from other sources that use different periods or TTM figures. Current Price, Market Cap and P/E reflect the live quote (cached 15 min).
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity